Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

REGiMMUNE Corp.

www.regimmune.com

Latest From Food & Drug Administration

Immuno-Oncology: Sneak Peek Of Preclinical Candidates Waiting In The Wings

Which immuno-oncology candidates are poised to begin their first-in-human clinical trials? How many sponsors already have partners or collaborators? What oncology indications have been proposed? And where will these trials take place? Citeline's Rachel L. Meighan-Mantha has the data.

BioPharmaceutical Research & Development

INTERVIEW: Simplifying The Clinic's Digital Strategy

Mobile technology and wearables have been hailed by many as the golden future for operational efficiency and patient retention in clinical studies. Digital engagement expert Tim Davis discusses the pitfalls of selecting a one-size-fits-all strategy and waiting for trial processes and regulators to catch up.

Strategy Clinical Trials

Sports Medicine: Game-Changing Technologies

Sports medicine is the fastest growing specialty in orthopedics, attracting more than 25% of orthopedic residents seeking fellowships for the 2010 training year. Since many sports injuries occur in the young athlete, the way an injury is treated early on may be the determining factor in preventing progressive joint changes and the early onset of degenerative diseases such as osteoarthritis. The promise of new biomaterials and biologics for repairing or replacing supporting soft tissue structures will have a big impact on the orthopedics market for some time to come.
Medical Device

Market & Industry Briefs

Brief summaries of recent medtech market and industry developments. This month we cover new challenges to the medical imaging industry and to the efficacy of vertebroplasty procedures, final results from the MADIT-CRT trial, and new developments in the percutaneous heart valve replacement and repair market.
Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • REGiMMUNE Corp.
  • Senior Management
  • Haru Morita, Pres. & CEO
    Reiko Namikawa, MD, PhD, SVP, Dev. & Strategy
    Teikichi Aoyagi, PhD, SVP, Chief Dev. Officer
  • Contact Info
  • REGiMMUNE Corp.
    Phone: (81) 3 3456 0820
    Tokyo Industry Trade Ctr. 607
    1-7-8 Kaigan
    Tokyo, 105-0022
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register